A look back at the expansion of the LFB Biomanufacturing plant in Alès

Laying the foundation stone, a tour of production and discussions on the importance of France's health and industrial independence were on the programme for this eventful afternoon: the kick-off to strengthening of the French bioproduction sector.

Because more than half of the medicines of tomorrow are biotherapies, and to meet the growing needs of patients, the expansion of LFB’s plant in Alès will mean that more biomedicinal products can be produced right in France.

LFB thanks all those who made the "France2030” project possible: elected officials, administrations and local stakeholders in the Gard department of France.
A special thanks goes out to the women and men of LFB.